Debunking the Rumors: Why Was Aimovig Discontinued?
•
3 min read
Since its FDA approval in 2018, Aimovig (erenumab-aooe) has been a key player in migraine prevention [1.2.5]. Despite rumors, if you're asking 'Why was Aimovig discontinued?', the simple answer is: it hasn't been. The confusion stems from a significant change in its commercial partnership.
